Don't miss out and join us tomorrow for event 8 in the ‘Precision medicine in oncology’ series surrounding the history of CAR-T, research, scientific evidence, and approval. Two international experts will share their experience of the use of CAR-T. labroots.com/virtual-event/…

Only 3 days to go until we will be in Chicago for ASCO . Schedule a meeting with one of our experts to learn more about how Diaceutics are uniquely positioned to help you achieve commercialization success for your precision medicine. Link: go.diaceutics.com/ASCO2024

DXRX Signal delivers an actionable alert of a testing behavior, allowing you to engage a physician during the treatment decision timeframe, maximizing effectiveness of your sales and marketing activities. Meet our team at ASCO to learn more: go.diaceutics.com/ASCO2024 #ASCO2024

We are delighted to have two of our abstracts accepted for poster presentation and online publication at this year’s ASCO. Read more here: tinyurl.com/3e386azb. Schedule a meeting with one of our solution experts at ASCO using the link below: lnkd.in/gnZMEG3p #ASCO2024

ASCO daily highlights Our team on the ground share some key highlights from an exciting first day at ASCO 2024. Follow us for more daily highlights throughout the conference! Read highlights here: lnkd.in/e5e2w-F5 #ASCO24 #ASCO2024

ASCO daily highlights: Saturday 1st June Read our key highlights from day 2 at ASCO. Stay tuned to our LinkedIn page where we will be sharing our precision medicine expert daily highlights throughout the conference. Read here: lnkd.in/ei4-nrdj #ASCO2024 #ASCO24

We are delighted to have our research accepted for poster presentation at ASCO this year. Don’t miss Ying Liu, one of our abstract authors, who will be presenting this research during the morning session today at ASCO, 9:00 am to 12:00 pm, Hall A. #ASCO2024 #ASCO24

ASCO daily highlights: Sunday 2nd June Read our key highlights from day 3 at ASCO. Stay tuned to our LinkedIn page where we will be sharing our daily highlights throughout the conference. Read here: diaceutics.com/articles/asco-… #ASCO2024 #ASCO24

New blog! Navigating the New Amendments to the EU In Vitro Devices Regulation (IVDR). In our latest blog, Dave Smart, Snr Dir. of Analytics at Diaceutics shares key highlights and provides insights into these significant changes and their implications. dxrx.io/articles/artic…

ASCO daily highlights: Monday 3rd June Our team have had an amazing week at ASCO meeting with both new and existing customers and learning about the latest advancements in the field of oncology. Read our highlights here: diaceutics.com/articles/asco-… #ASCO2024 #ASCO24

Our team had an amazing time in Chicago for ASCO 2024, meeting both new and existing customers and learning about the latest findings in oncology research. Read our latest blog where we share our key highlights from ASCO. Read blog here: lnkd.in/dE_VxBgM #ASCO2024 #ASCO24

Sign up for event 9 in the 'Precision medicine in solid tumors event'. This session will review updates and challenges associated with assessment of thyroid FNAs, focusing on recognizing cytomorphology patters of thyroid FNA. Don’t miss out! labroots.com/ms/virtual-eve…

5 day countdown! 🕔 Time is running out to sign up to our Precision Medicine in Oncology virtual event held on the 19th June. Register now: tinyurl.com/yc4p9nav Want to stay up to date with the latest DXRX news & events? Join the DXRX community and follow DXRX: The Diagnostic Network®

Not long until the next Diaceutics virtual event, Precision medicine in oncology! Attendees will gain a deeper understanding of relevant topics such as liquid biopsy, MRD , early-stage cancer, genomic profiling, and artificial intelligence tools. labroots.com/virtual-event/…

Calling all lab experts 🧬 Join us TODAY for our exciting Precision Medicine in Oncology virtual event. First talk is at 11am CEST with Prof. Dr. Klaus Pantel. Don't miss out! bit.ly/PMIO #oncology #pathtwitter #pathology Labroots

Professor Zannoni shares his experience of European collaboration on endometrial cancer testing, the impact of this collaboration on the scientific lab community and working with Diaceutics on the project. Read the report now - lp.diaceutics.com/endometrial-pa… #Endometrialcancer

New webinar series! Led by Diaceutics’ in-house precision medicine experts to provide valuable insights to overcome challenges in the PM market and drive commercial success for your targeted therapy. Join us for our first webinar on Thursday, September 5, 2024, from 1-2pm EDT.

📢 Join Diaceutics PLC for an upcoming webinar to discover how to optimize precision medicine and targeted therapies! ➡️ Learn about market trends, strategic insights, and cost-efficient approaches for successful commercialization: buff.ly/3Ma4DFl #PrecisionMedicine

Episode 5 of the Better testing, Better Treatment podcast is now LIVE! In episode 5, Dr James Solomon & Ashish Saxena, MD, PhD delve into the practical considerations for oncogenic fusion detection, reporting & guide treatments. tinyurl.com/Oncogenic-Fusi… #OncogenicFusions

An exciting update for our #podcast listeners! Our podcast is now available on Spotify and Apple Podcasts 🎙️ Don't miss out on our newest episode, 'Oncogenic Fusion detection and reporting in NSCLC and solid tumors: from clinic to lab' Listen now - …tertestingbettertreatment.podbean.com